Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 1651 AL 1665

Spiritual care for the management of Parkinson's disease: Where we are and how far can we go

Gao J, Wang Q, Wu Q, Weng Y, Lu H, Xu J.

Psychogeriatrics. 2022 Jul;22(4):521-529. doi: 10.1111/psyg.12834. Epub 2022 May 29.

Application of Neurotoxin-Induced Animal Models in the Study of Parkinson's Disease-Related Depression: Profile and Proposal

Mou YK, Guan LN, Yao XY, Wang JH, Song XY, Ji YQ, Ren C, Wei SZ.

Front Aging Neurosci. 2022 May 13;14:890512. doi: 10.3389/fnagi.2022.890512. eCollection 2022.

The Double-Faceted Role of Leucine-Rich Repeat Kinase 2 in the Immunopathogenesis of Parkinson's Disease

Zhang M, Li C, Ren J, Wang H, Yi F, Wu J, Tang Y.

Front Aging Neurosci. 2022 May 11;14:909303. doi: 10.3389/fnagi.2022.909303. eCollection 2022.

Association Between Rheumatoid Arthritis and Risk of Parkinson's Disease: A Meta-Analysis and Systematic Review

Li D, Hong X, Chen T.

Front Neurol. 2022 May 11;13:885179. doi: 10.3389/fneur.2022.885179. eCollection 2022.

Deciphering the Structure and Formation of Amyloids in Neurodegenerative Diseases With Chemical Biology Tools

Landrieu I, Dupré E, Sinnaeve D, El Hajjar L, Smet-Nocca C.

Front Chem. 2022 May 12;10:886382. doi: 10.3389/fchem.2022.886382. eCollection 2022.

Role of Environmental Toxicants on Neurodegenerative Disorders

Nabi M, Tabassum N.

Front Toxicol. 2022 May 11;4:837579. doi: 10.3389/ftox.2022.837579. eCollection 2022.

Electrocardiographic abnormalities in a patient with pre-excitation and acute myocardial infarction undergoing percutaneous coronary intervention and ablation

Chin CG, Chen WT, Lin YK, Chung CC, Hsieh MH.

J Chin Med Assoc. 2022 Jul 1;85(7):804-807. doi: 10.1097/JCMA.0000000000000750. Epub 2022 Jun 30.

Parkinsonism in idiopathic normal pressure hydrocephalus: is it time for defining a clinical tetrad?

Mostile G, Fasano A, Zappia M.

Neurol Sci. 2022 Sep;43(9):5201-5205. doi: 10.1007/s10072-022-06119-3. Epub 2022 Jun 1.

Imaging Neuroinflammation in Neurodegenerative Disorders

Masdeu JC, Pascual B, Fujita M.

J Nucl Med. 2022 Jun;63(Suppl 1):45S-52S. doi: 10.2967/jnumed.121.263200.

Altered neural cell junctions and ion-channels leading to disrupted neuron communication in Parkinson's disease

Choudhury SP, Bano S, Sen S, Suchal K, Kumar S, Nikolajeff F, Dey SK, Sharma V.

NPJ Parkinsons Dis. 2022 Jun 1;8(1):66. doi: 10.1038/s41531-022-00324-9.

Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Steatohepatitis and Neurodegenerative diseases: A Narrative Review

Mahapatra MK, Karuppasamy M, Sahoo BM.

Pharm Res. 2022 Jun;39(6):1233-1248. doi: 10.1007/s11095-022-03302-1. Epub 2022 Jun 1.

Editorial: Experimental and Innovative Approaches to Multi-Target Treatment of Parkinson's and Alzheimer's Diseases

Tikhonova MA, Chang HM, Singh SK, Vieau D.

Front Neurosci. 2022 May 16;16:910020. doi: 10.3389/fnins.2022.910020. eCollection 2022.

Human Brain-Based Models Provide a Powerful Tool for the Advancement of Parkinson's Disease Research and Therapeutic Development

McComish SF, MacMahon Copas AN, Caldwell MA.

Front Neurosci. 2022 May 16;16:851058. doi: 10.3389/fnins.2022.851058. eCollection 2022.

Troubleshooting Gait Disturbances in Parkinson's Disease With Deep Brain Stimulation

Pozzi NG, Palmisano C, Reich MM, Capetian P, Pacchetti C, Volkmann J, Isaias IU.

Front Hum Neurosci. 2022 May 16;16:806513. doi: 10.3389/fnhum.2022.806513. eCollection 2022.

Modeling Parkinson's disease-related symptoms in alpha-synuclein overexpressing mice

Aniszewska A, Bergström J, Ingelsson M, Ekmark-Lewén S.

Brain Behav. 2022 Jul;12(7):e2628. doi: 10.1002/brb3.2628. Epub 2022 Jun 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias